Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 32

RecargaPay tops up series C to $80m

The mobile payment app developer has expanded an Experian-backed round with a $10m extension, taking its total funding to approximately $110m.

Nov 2, 2021

Cover builds out $60m series B

Existing investor Lennar returned to back the modular homebuilder in a round led by Gigafund, bringing its overall funding to over $71m.

Nov 2, 2021

Aculys Pharma accepts SoftBank-led round

SoftBank’s Vision Fund 2 led a $59.7m round which will support Aculys in bringing a sleep disorder medication it has licensed to Japan.

Nov 2, 2021

Daily Deal Round Up: November 1, 2021

Cell therapy developer Hopstem completed a $40m Eli Lilly-backed series B round while cybersecurity technology developer SlashNext secured $26m from investors including Telia and Ayala Group.

Nov 1, 2021

Infinium gets $69m funding influx

The electofuel provider's latest round was co-led by NextEra Energy Resources and Amazon Climate Pledge Fund and included Mitsubishi Heavy Industries.

Nov 1, 2021

Daily Deal Round Up: October 29, 2021

Wells Fargo Strategic Capital took part in a $52.5m round for digital mortgage platform developer Maxwell while corporate-backed music distributor UnitedMasters closed a $50m series C.

Oct 29, 2021

Daily Deal Round Up: October 28, 2021

Cybersecurity software developer Sonrai Security, small business insurance provider Coterie and fashion brand Love, Bonito each raised $50m in corporate-backed rounds.

Oct 28, 2021

Crossbeam shines with $76m series C

Salesforce Ventures, Slack Fund, HubSpot Ventures and Okta Ventures all returned to back the commercial partnership platform developer.

Oct 28, 2021

Pipefy lets through $75m

SoftBank Latin American Fund was the largest investor in a round bringing the workflow software provider’s funding to approximately $139m to date.

Oct 28, 2021

Juventas receives $63m injection

The Casi Pharmaceuticals-backed immunotherapy developer has completed a $63m series C round co-led by CICC and Oceanpine Capital.

Oct 28, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here